Nekane Garcia-Terrades

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies.

Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies.

Journal: Rheumatology (Oxford, England)

Published: September 03, 2019

Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma.

Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma.

Journal: Molecular oncology

Published: April 05, 2019

Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.

Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.

Journal: Frontiers in immunology

Published: December 14, 2017

Biological treatments in giant cell arteritis & Takayasu arteritis.

Biological treatments in giant cell arteritis & Takayasu arteritis.

Journal: European journal of internal medicine

Published: October 24, 2017

Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.

Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.

Journal: RMD open

Published: September 04, 2017

Pathogenesis of giant-cell arteritis: how targeted therapies are influencing our understanding of the mechanisms involved.

Pathogenesis of giant-cell arteritis: how targeted therapies are influencing our understanding of the mechanisms involved.

Journal: Rheumatology (Oxford, England)

Published: June 30, 2017

Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis.

Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis.

Journal: Annals of the rheumatic diseases

Published: November 08, 2016

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.

Journal: Annals of the rheumatic diseases

Published: August 04, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026